Literature DB >> 3936090

EEG effects of i.v. infusion of pentylenetetrazol in rats: a model for screening and classifying antiepileptic compounds.

V Santucci, M Fournier, P Keane, J Simiand, J C Michaud, M Morre, K Biziere.   

Abstract

In order to validate a new animal model predictive of the profile of antiepileptic drugs, we studied the antagonism by standard antiepileptics of the EEG modifications induced by low-speed IV infusion of pentylenetetrazol (PTZ) in rats. The activity of the drugs was measured by their effects on temporal characteristics of the PTZ-induced EEG paroxysms. Most compounds had moderate to potent anti-PTZ effects, as shown by the changes in the EEG temporal parameters. However, these effects depended on the drugs and doses. Cluster analysis showed that drugs and doses which evoked similar changes were closely related and were included in separate clusters with respect to one another. In particular, the present results showed that benzodiazepines and antiepileptics cluster differently in their effects. Thus, this model could be a useful tool for assessing new antiepileptic drugs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936090     DOI: 10.1007/bf00432718

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  11 in total

1.  Quantitative evaluation of the pentylenetetrazol-anticonvulsant interaction on the EEG of the cat.

Authors:  C L Faingold; C A Berry
Journal:  Eur J Pharmacol       Date:  1973-12       Impact factor: 4.432

2.  [Pharmacokinetics of di-n-propylacetamide in rats after oral administration].

Authors:  J Simiand; P Eymard; B Ferrandes; M Polverelli
Journal:  Ann Pharm Fr       Date:  1973-03

3.  A study on the metabolism of dipropylacetamide to dipropylacetic acid in rats.

Authors:  F Pisani; A Fazio; G Oteri; R Di Perri
Journal:  J Pharm Pharmacol       Date:  1982-01       Impact factor: 3.765

4.  Antagonism of maximal metrazol seizures in rats and its relevance to an experimental classification of antiepileptic drugs.

Authors:  L K Desmedt; C J Niemegeers; P J Lewi; P A Janssen
Journal:  Arzneimittelforschung       Date:  1976

5.  Do different anticonvulsant tests provide the same information concerning the profiles of antiepileptic activity?

Authors:  R Testa; L Graziani; G Graziani
Journal:  Pharmacol Res Commun       Date:  1983-09

Review 6.  Benzodiazepines in the treatment of epilepsy. A review.

Authors:  T R Browne; J K Penry
Journal:  Epilepsia       Date:  1973-09       Impact factor: 5.864

7.  Computer EEG drug data base in psychopharmacology and in drug development.

Authors:  T M Itil; G N Menon; K Z Itil
Journal:  Psychopharmacol Bull       Date:  1982-10

8.  Dipropylacetic acid plasma levels; diurnal fluctuations during chronic treatment with dipropylacetamide.

Authors:  F Pisani; A Fazio; G Oteri; R Di Perri
Journal:  Ther Drug Monit       Date:  1981       Impact factor: 3.681

9.  Some clinical pharmacological aspects of n-dipropylacetamide.

Authors:  F Pisani; R Di Perri
Journal:  Ital J Neurol Sci       Date:  1980-10

10.  Differential antagonisms of anticonvulsants to various components of maximal seizures induced by electroshock or pentylenetetrazol in mice.

Authors:  Y Masuda; Y Shiraishi; T Karasawa; K Yoshida; M Shimizu
Journal:  J Pharmacobiodyn       Date:  1980-10
View more
  2 in total

1.  An examination of the anticonvulsant properties of voltage-sensitive calcium channel inhibitors in amygdala kindled seizures.

Authors:  C M Mack; M E Gilbert
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Neurochemical and behavioral features in genetic absence epilepsy and in acutely induced absence seizures.

Authors:  A S Bazyan; G van Luijtelaar
Journal:  ISRN Neurol       Date:  2013-05-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.